An overview of mammographic density and its association with breast cancer Shayan Shaghayeq NazariPinku Mukherjee Review Article Open access 12 April 2018 Pages: 259 - 267
Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer Hiroaki InoueRie HoriiFutoshi Akiyama Original Article 28 November 2017 Pages: 268 - 274
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study Steffen DörfelClaus-Christoph SteffensThe TMK-Group (Tumour Registry Breast Cancer) Original Article Open access 04 December 2017 Pages: 275 - 283
B-cell populations are expanded in breast cancer patients compared with healthy controls Banri TsudaAsuka MiyamotoYutaka Tokuda Original Article Open access 04 December 2017 Pages: 284 - 291
TERT promoter hotspot mutations in breast cancer Tatsunori ShimoiMasayuki YoshidaKenji Tamura Original Article Open access 08 December 2017 Pages: 292 - 296
HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer Abdelfattah M. AttallahMohamed El-FarIbrahim El-Dosoky Original Article 28 December 2017 Pages: 297 - 302
Body image and psychological distress in women with breast cancer: a French online survey on patients’ perceptions and expectations Camille PierrisnardMarjorie BaciuchkaMarc Montana Original Article 29 December 2017 Pages: 303 - 308
The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study Li ZouFeng-hua LiuYe Tian Original Article 03 February 2018 Pages: 309 - 314
The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual Zheng-Jun YangYue YuXu-Chen Cao Original Article 20 January 2018 Pages: 315 - 324
Foot posture in female patients 5 years after breast-conserving surgery: a case–control study Iwona Głowacka-MrotekMagdalena SowaWojciech Zegarski Original Article Open access 24 January 2018 Pages: 325 - 333
Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and 18F-FDG-PET Huong Nguyen-ThuHirofumi HanaokaYoshito Tsushima Original Article 22 January 2018 Pages: 334 - 342
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study Yukinori OzakiYuko TanabeToshimi Takano Original Article Open access 22 January 2018 Pages: 343 - 349
Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan Rabbia Tariq KhanAyesha SiddiqueWarda Fatima Original Article 24 January 2018 Pages: 350 - 355
Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON) Shinzaburo NoguchiMatthew J. EllisZhimin Shao Original Article 15 February 2018 Pages: 356 - 364
Primary squamous cell carcinoma of the breast in association with Zuska’s disease A. M. HuwsL. SemkinY. M. Sharaiha Case Report 17 November 2017 Pages: 365 - 369
Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine Xavier PivotSeock Ah ImFrederik Marmé Rapid Communication Open access 04 January 2018 Pages: 370 - 374